Rare Variants in 48 Genes Account for 42% of Cases of Epilepsy With or Without Neurodevelopmental Delay in 246 Pediatric Patients

In order to characterize the genetic architecture of epilepsy in a pediatric population from the Iberian Peninsula (including the Canary Islands), we conducted targeted exome sequencing of 246 patients with infantile-onset seizures with or without neurodevelopmental delay. We detected 107 variants in 48 different genes, which were implicated in neuronal excitability, neurodevelopment, synaptic transmission, and metabolic pathways. In 104 cases (42%) we detected variant(s) that we classified as pathogenic or likely pathogenic. Of the 48 mutated genes, 32 were dominant, 8 recessive and 8 X-linked. Of the patients for whom family studies could be performed and in whom pathogenic variants were identified in dominant or X-linked genes, 82% carried de novo mutations. The involvement of small copy number variations (CNVs) is 9%. The use of progressively updated custom panels with high mean vertical coverage enabled establishment of a definitive diagnosis in a large proportion of cases (42%) and detection of CNVs (even duplications) with high fidelity. In 10.5% of patients we detected associations that are pending confirmation via functional and/or familial studies. Our findings had important consequences for the clinical management of the probands, since a large proportion of the cohort had been clinically misdiagnosed, and their families were subsequently able to avail of genetic counseling. In some cases, a more appropriate treatment was selected for the patient in question, or an inappropriate treatment discontinued. Our findings suggest the existence of modifier genes that may explain the incomplete penetrance of some epilepsy-related genes. We discuss possible reasons for non-diagnosis and future research directions. Further studies will be required to uncover the roles of structural variants, epimutations, and oligogenic inheritance in epilepsy, thereby providing a more complete molecular picture of this disease. In summary, given the broad phenotypic spectrum of most epilepsy-related genes, efficient genomic tools like the targeted exome sequencing panel described here are essential for early diagnosis and treatment, and should be implemented as first-tier diagnostic tools for children with epilepsy without a clear etiologic basis.

[1]  M. Couce,et al.  PattRec: An easy-to-use CNV detection tool optimized for targeted NGS assays with diagnostic purposes. , 2020, Genomics.

[2]  A. El-Hattab,et al.  West syndrome, developmental and epileptic encephalopathy, and severe CNS disorder associated with WWOX mutations. , 2018, Epileptic disorders : international epilepsy journal with videotape.

[3]  C. Zai,et al.  Novel and de novo mutations in pediatric refractory epilepsy , 2018, Molecular Brain.

[4]  E. Farrow,et al.  Incidental diagnosis of tuberous sclerosis complex by exome sequencing in three families with subclinical findings , 2018, neurogenetics.

[5]  S. Traynelis,et al.  A novel missense mutation in GRIN2A causes a nonepileptic neurodevelopmental disorder , 2018, Movement disorders : official journal of the Movement Disorder Society.

[6]  R. Miles,et al.  Second-hit mosaic mutation in mTORC1 repressor DEPDC5 causes focal cortical dysplasia–associated epilepsy , 2018, The Journal of clinical investigation.

[7]  M. Couce,et al.  Prioritization of Variants Detected by Next Generation Sequencing According to the Mutation Tolerance and Mutational Architecture of the Corresponding Genes , 2018, International journal of molecular sciences.

[8]  R. Rosch,et al.  Incorporating epilepsy genetics into clinical practice: a 360°evaluation , 2018, npj Genomic Medicine.

[9]  A. Fattal-Valevski,et al.  Detection of copy number variations in epilepsy using exome data , 2018, Clinical genetics.

[10]  S. Baulac,et al.  Review: Mechanistic target of rapamycin (mTOR) pathway, focal cortical dysplasia and epilepsy , 2018, Neuropathology and applied neurobiology.

[11]  L. Vissers,et al.  Identification of rare de novo epigenetic variations in congenital disorders , 2018, bioRxiv.

[12]  A. Bassett,et al.  Prevalence of Pathogenic Copy Number Variation in Adults With Pediatric-Onset Epilepsy and Intellectual Disability , 2017, JAMA neurology.

[13]  Amanda S. Lindy,et al.  High frequency of mosaic pathogenic variants in genes causing epilepsy-related neurodevelopmental disorders , 2017, Genetics in Medicine.

[14]  A. Grottesi,et al.  Lethal digenic mutations in the K+ channels Kir4.1 (KCNJ10) and SLACK (KCNT1) associated with severe-disabling seizures and neurodevelopmental delay. , 2017, Journal of neurophysiology.

[15]  G. Mancini,et al.  Male patients affected by mosaic PCDH19 mutations: five new cases , 2017, neurogenetics.

[16]  H. Lerche,et al.  The role of genetic testing in epilepsy diagnosis and management , 2017, Expert review of molecular diagnostics.

[17]  J. Kearney,et al.  Cacna1g is a genetic modifier of epilepsy in a mouse model of Dravet syndrome , 2017, Epilepsia.

[18]  A. Fatemi,et al.  FOXG1 syndrome: genotype–phenotype association in 83 patients with FOXG1 variants , 2017, Genetics in Medicine.

[19]  Dong Seok Kim,et al.  Somatic Mutations in TSC1 and TSC2 Cause Focal Cortical Dysplasia. , 2017, American journal of human genetics.

[20]  R. Guerrini,et al.  The Impact of Next-Generation Sequencing on the Diagnosis and Treatment of Epilepsy in Paediatric Patients , 2017, Molecular Diagnosis & Therapy.

[21]  G. Cooper,et al.  Germline and somatic mutations in the MTOR gene in focal cortical dysplasia and epilepsy , 2016, Neurology: Genetics.

[22]  J. García-Peñas,et al.  Clinical and genetic features of 13 Spanish patients with KCNQ2 mutations , 2016, Journal of Human Genetics.

[23]  Arthur P. Grollman,et al.  Genome-wide quantification of rare somatic mutations in normal human tissues using massively parallel sequencing , 2016, Proceedings of the National Academy of Sciences.

[24]  Beth K. Martin,et al.  Association of MTOR Mutations With Developmental Brain Disorders, Including Megalencephaly, Focal Cortical Dysplasia, and Pigmentary Mosaicism. , 2016, JAMA neurology.

[25]  Jae Seok Lim,et al.  Brain somatic mutations in MTOR leading to focal cortical dysplasia , 2016, BMB reports.

[26]  D. Pinto,et al.  Identification of novel genetic causes of Rett syndrome-like phenotypes , 2016, Journal of Medical Genetics.

[27]  J. Conroy,et al.  Unexplained early onset epileptic encephalopathy: Exome screening and phenotype expansion , 2016, Epilepsia.

[28]  G. Carvill,et al.  Mutations in KCNT1 cause a spectrum of focal epilepsies , 2015, Epilepsia.

[29]  H. Kitaura,et al.  Somatic Mutations in the MTOR gene cause focal cortical dysplasia type IIb , 2015, Annals of neurology.

[30]  Heather C Mefford,et al.  Copy Number Matters in Epilepsy , 2015, Epilepsy currents.

[31]  Michael R. Johnson,et al.  Copy number variant analysis from exome data in 349 patients with epileptic encephalopathy , 2015, Annals of neurology.

[32]  B. Li,et al.  The SCN1A Mutation Database: Updating Information and Analysis of the Relationships among Genotype, Functional Alteration, and Phenotype , 2015, Human mutation.

[33]  R. Weksberg,et al.  Diagnostic yield of genetic testing in epileptic encephalopathy in childhood , 2015, Journal of the Neurological Sciences.

[34]  Seok-Gu Kang,et al.  Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy , 2015, Nature Medicine.

[35]  Bale,et al.  Standards and Guidelines for the Interpretation of Sequence Variants: A Joint Consensus Recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology , 2015, Genetics in Medicine.

[36]  Epilepsy Phenome,et al.  De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. , 2014, American journal of human genetics.

[37]  G. McVean,et al.  Integrating mapping-, assembly- and haplotype-based approaches for calling variants in clinical sequencing applications , 2014, Nature Genetics.

[38]  S. Noachtar,et al.  Exonic microdeletions of the gephyrin gene impair GABAergic synaptic inhibition in patients with idiopathic generalized epilepsy , 2014, Neurobiology of Disease.

[39]  P. Awadalla,et al.  Genetically encoded impairment of neuronal KCC2 cotransporter function in human idiopathic generalized epilepsy , 2014, EMBO reports.

[40]  I. Scheffer,et al.  A variant of KCC2 from patients with febrile seizures impairs neuronal Cl− extrusion and dendritic spine formation , 2014, EMBO reports.

[41]  Peter Donnelly,et al.  Clinical whole-genome sequencing in severe early-onset epilepsy reveals new genes and improves molecular diagnosis , 2014, Human molecular genetics.

[42]  Michael R. Johnson,et al.  De novo mutations in the classic epileptic encephalopathies , 2013, Nature.

[43]  C. Walsh,et al.  Somatic Mutation, Genomic Variation, and Neurological Disease , 2013, Science.

[44]  M. Spielmann,et al.  CNVs of noncoding cis-regulatory elements in human disease. , 2013, Current opinion in genetics & development.

[45]  S. Scherer,et al.  Rare exonic deletions implicate the synaptic organizer Gephyrin (GPHN) in risk for autism, schizophrenia and seizures. , 2013, Human molecular genetics.

[46]  A. Brooks-Kayal,et al.  Down‐regulation of gephyrin and GABAA receptor subunits during epileptogenesis in the CA1 region of hippocampus , 2013, Epilepsia.

[47]  Holger Lerche,et al.  Rare exonic deletions of the RBFOX1 gene increase risk of idiopathic generalized epilepsy , 2013, Epilepsia.

[48]  H. Mefford,et al.  Exon‐disrupting deletions of NRXN1 in idiopathic generalized epilepsy , 2013, Epilepsia.

[49]  P. Genton,et al.  PRRT2 links infantile convulsions and paroxysmal dyskinesia with migraine , 2012, Neurology.

[50]  L. Kaczmarek,et al.  De novo gain-of-function KCNT1 channel mutations cause malignant migrating partial seizures of infancy , 2012, Nature Genetics.

[51]  Bradley P. Coe,et al.  A genetic model for neurodevelopmental disease , 2012, Current Opinion in Neurobiology.

[52]  Data production leads,et al.  An integrated encyclopedia of DNA elements in the human genome , 2012 .

[53]  Meredith Wilson,et al.  The CDKL5 disorder is an independent clinical entity associated with early-onset encephalopathy , 2012, European Journal of Human Genetics.

[54]  S. Gallati,et al.  Targeted next generation sequencing as a diagnostic tool in epileptic disorders , 2012, Epilepsia.

[55]  ENCODEConsortium,et al.  An Integrated Encyclopedia of DNA Elements in the Human Genome , 2012, Nature.

[56]  Pablo Cingolani,et al.  © 2012 Landes Bioscience. Do not distribute. , 2022 .

[57]  J. Jankovic,et al.  Mutations in the gene PRRT2 cause paroxysmal kinesigenic dyskinesia with infantile convulsions. , 2012, Cell reports.

[58]  I. Scheffer,et al.  Rare copy number variants are an important cause of epileptic encephalopathies , 2011, Annals of neurology.

[59]  Caleb Davis,et al.  Exome Sequencing of Ion Channel Genes Reveals Complex Profiles Confounding Personal Risk Assessment in Epilepsy , 2011, Cell.

[60]  A. Gonzalez-Perez,et al.  Improving the assessment of the outcome of nonsynonymous SNVs with a consensus deleteriousness score, Condel. , 2011, American journal of human genetics.

[61]  Melinda S. Martin,et al.  Neuronal voltage-gated ion channels are genetic modifiers of generalized epilepsy with febrile seizures plus , 2011, Neurobiology of Disease.

[62]  Serafim Batzoglou,et al.  Identifying a High Fraction of the Human Genome to be under Selective Constraint Using GERP++ , 2010, PLoS Comput. Biol..

[63]  Kate M. Lawrence,et al.  Timing of de novo mutagenesis--a twin study of sodium-channel mutations. , 2010, The New England journal of medicine.

[64]  M. DePristo,et al.  The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. , 2010, Genome research.

[65]  Michael R. Johnson,et al.  Rare deletions at 16p13.11 predispose to a diverse spectrum of sporadic epilepsy syndromes. , 2010, American journal of human genetics.

[66]  Tomas W. Fitzgerald,et al.  Origins and functional impact of copy number variation in the human genome , 2010, Nature.

[67]  Aaron R. Quinlan,et al.  BIOINFORMATICS APPLICATIONS NOTE , 2022 .

[68]  I. Scheffer,et al.  Familial and sporadic 15q13.3 microdeletions in idiopathic generalized epilepsy: precedent for disorders with complex inheritance. , 2009, Human molecular genetics.

[69]  Ken Chen,et al.  VarScan: variant detection in massively parallel sequencing of individual and pooled samples , 2009, Bioinform..

[70]  Christian E Elger,et al.  CLCN2 variants in idiopathic generalized epilepsy , 2009, Nature Genetics.

[71]  Kai Ye,et al.  Pindel: a pattern growth approach to detect break points of large deletions and medium sized insertions from paired-end short reads , 2009, Bioinform..

[72]  Gonçalo R. Abecasis,et al.  The Sequence Alignment/Map format and SAMtools , 2009, Bioinform..

[73]  Richard Durbin,et al.  Sequence analysis Fast and accurate short read alignment with Burrows – Wheeler transform , 2009 .

[74]  C. Béroud,et al.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals , 2009, Nucleic acids research.

[75]  H. Lerche,et al.  Two novel CLCN2 mutations accelerating chloride channel deactivation are associated with idiopathic generalized epilepsy , 2009, Human Mutation.

[76]  Christian E Elger,et al.  15q13.3 microdeletions increase risk of idiopathic generalized epilepsy , 2009, Nature Genetics.

[77]  C. Depienne,et al.  Spectrum of SCN1A gene mutations associated with Dravet syndrome: analysis of 333 patients , 2008, Journal of Medical Genetics.

[78]  A. Konagaya,et al.  Microchromosomal deletions involving SCN1A and adjacent genes in severe myoclonic epilepsy in infancy , 2008, Epilepsia.

[79]  Jing Qian,et al.  Masking epilepsy by combining two epilepsy genes , 2007, Nature Neuroscience.

[80]  E. Bertini,et al.  Familial Occurrence of Febrile Seizures and Epilepsy in Severe Myoclonic Epilepsy of Infancy (SMEI) Patients with SCN1A Mutations , 2006, Epilepsia.

[81]  E. Bertini,et al.  Somatic and germline mosaicisms in severe myoclonic epilepsy of infancy. , 2006, Biochemical and biophysical research communications.

[82]  K. Yamakawa,et al.  A missense mutation in SCN1A in brothers with severe myoclonic epilepsy in infancy (SMEI) inherited from a father with febrile seizures , 2005, Brain and Development.

[83]  H. Oguni,et al.  Mutations of Neuronal Voltage‐gated Na+ Channel α1 Subunit Gene SCN1A in Core Severe Myoclonic Epilepsy in Infancy (SMEI) and in Borderline SMEI (SMEB) , 2004, Epilepsia.

[84]  Federico Zara,et al.  Familial severe myoclonic epilepsy of infancy: truncation of Nav1.1 and genetic heterogeneity. , 2003, Epileptic disorders : international epilepsy journal with videotape.

[85]  T. Wienker,et al.  Genome search for susceptibility loci of common idiopathic generalised epilepsies. , 2000, Human molecular genetics.

[86]  A. Fatemi,et al.  FOXG 1 syndrome : genotype – phenotype association in 83 patients with FOXG 1 variants , 2017 .

[87]  Michael R. Johnson,et al.  De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies. , 2014, American journal of human genetics.

[88]  S. Baulac.  mTOR signaling pathway genes in focal epilepsies. , 2016, Progress in brain research.

[89]  De novo mutations in epileptic encephalopathies , 2013 .

[90]  C. Baker,et al.  Recurrent microdeletions at 15q11.2 and 16p13.11 predispose to idiopathic generalized epilepsies. , 2010, Brain : a journal of neurology.

[91]  S. Horvath,et al.  Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies , 2003, Nature Genetics.

[92]  K. Shadan,et al.  Available online: , 2012 .